🇺🇸
United States · US · US:52544-695_6b586f35-6eb1-488c-839e-581f695d3f07
Matzim LA
In shortageOrange BookUNIISPLATC C05AE03
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerActavis Pharma, Inc.
CountryUS (United States)
ATC codeC05AE03
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc11525446951990 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-695-19)
- ndc11525446953030 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (52544-695-30)
Annotations
UNII (FDA Substance ID)
OLH94387TE
DILTIAZEM HYDROCHLORIDE
RxCUI 203211
Orange Book
A077686
ABABABABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Diltiazem Hydrochloride Injection
Raw payload (JSON)
{
"unii": {
"unii": "OLH94387TE",
"rxcui": "203211",
"inchikey": "HDRXZJPWHTXQRI-BHDTVMLSSA-N",
"display_name": "DILTIAZEM HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"e8c8dd18-9d95-4068-9762-bec1eb1bc25c": {
"match": "brand_token",
"title": "MATZIM LA (DILTIAZEM HYDROCHLORIDE) TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]",
"spl_version": "13",
"published_date": "2025-12-08"
}
},
"productid": "52544-695_6b586f35-6eb1-488c-839e-581f695d3f07",
"productndc": "52544-695",
"dosage_form": "TABLET, EXTENDED RELEASE",
"orange_book": {
"appl_no": "077686",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "420MG",
"product_no": "001",
"approval_date": "Mar 15, 2010"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "360MG",
"product_no": "002",
"approval_date": "Mar 15, 2010"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "300MG",
"product_no": "003",
"approval_date": "Mar 15, 2010"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "240MG",
"product_no": "004",
"approval_date": "Mar 15, 2010"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "180MG",
"product_no": "005",
"approval_date": "Mar 15, 2010"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "120MG",
"product_no": "006",
"approval_date": "Mar 15, 2010"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DILTIAZEM HYDROCHLORIDE",
"shortage_reason": "Diltiazem Hydrochloride Injection",
"shortage_status": "current",
"proprietary_name": "Matzim LA",
"active_ingred_unit": "mg/1",
"application_number": "ANDA077686",
"marketing_category": "ANDA",
"nonproprietary_name": "Diltiazem Hydrochloride",
"start_marketing_date": "20110328",
"active_numerator_strength": "420"
}Related drugs
Other records sharing ATC code C05AE03.
- GBAdizem-SR 120mg capsulesLexon (UK) Ltd
- GBAdizem-SR 120mg capsulesDE Pharmaceuticals
- GBAdizem-SR 120mg capsulesMawdsley-Brooks & Company Ltd
- GBAdizem-SR 120mg capsulesWaymade Healthcare Plc
- GBAdizem-SR 120mg capsulesNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsLexon (UK) Ltd
- GBAdizem-SR 180mg capsulesNapp Pharmaceuticals Ltd
Access this data programmatically
Query Matzim LA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.